Millennium Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Millennium Management’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.2M	Buy	+471,646	New	+$12.1M	0.01%	1979
2024 Q2	–	Sell	-560	Closed	-$10.9K	–	6119
2024 Q1	$10.9K	Buy	+560	New	+$9.96K	﹤0.01%	5915
2022 Q4	–	Sell	-752	Closed	-$36K	–	6726
2022 Q3	$36K	Sell	752 -462	-38%	-$23.4K	﹤0.01%	6285
2022 Q2	$53K	Buy	1,214 +59	+5%	+$2.71K	﹤0.01%	6180
2022 Q1	$64K	Buy	1,155 +45	+4%	+$2.53K	﹤0.01%	6320
2021 Q4	$84K	Sell	1,110 -2,224	-67%	-$175K	﹤0.01%	6320
2021 Q3	$299K	Buy	+3,334	New	+$356K	﹤0.01%	5819
2021 Q2	–	Sell	-3,314	Closed	-$503K	–	6722
2021 Q1	$503K	Buy	3,314 +514	+18%	+$140K	﹤0.01%	4823
2020 Q4	$875K	Buy	+2,800	New	+$1.04M	﹤0.01%	3820

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Millennium Management's DMRA Position: Q1 2026 in Review

Millennium Management opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 471,646 shares worth $12.2M. The stake represents 0.01% of the portfolio and ranks #1979 among its holdings. This is a return to the name: Millennium Management previously reported a position in DMRA as recently as Q1 2024.

Millennium Management first reported a position in DMRA in Q4 2020 and has held it in 9 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

Millennium Management held 471,646 shares of Damora Therapeutics, Inc. Ordinary Shares worth $12.2M as of Q1 2026.
Damora Therapeutics, Inc. Ordinary Shares was a new Millennium Management position in Q1 2026.
Damora Therapeutics, Inc. Ordinary Shares made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1979 holding.
Millennium Management first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2020 and has held it in 9 quarters since.
65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.